Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950162-04-001410
Filing Date
2004-12-09
Accepted
2004-12-09 16:34:55
Documents
2
Period of Report
2004-12-07

Document Format Files

Seq Description Document Type Size
1 elanform4120904_ex.html 4  
1 elanform4120904_ex.xml 4 4820
2 JOINT FILER INFORMATION elanform4ex99120904.txt EX-99 788
  Complete submission text file 0000950162-04-001410.txt   8010
Mailing Address LINCOLN HOUSE LINCOLN PLACE DUBLIN 2 L2 00000
Business Address LINCOLN HOUSE LINCOLN PLACE DUBLIN 2 L2 35317094000
ELAN CORP PLC (Reporting) CIK: 0000737572 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-26476 | Film No.: 041193720
SIC: 2834 Pharmaceutical Preparations

Mailing Address 31 ST JAMES AVE 8TH FL BOSTON MA 02116
Business Address 31 ST. JAMES AVENUE 8TH FLOOR BOSTON MA 02116 6174220674
GLYCOGENESYS INC (Issuer) CIK: 0000946661 (see all company filings)

EIN.: 330231238 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)